An InsideCounsel (subscription required) article by IP rights management partner Melissa Rones (Boston) in the February/March 2016 issue examines how life sciences companies are impacted by the recent Supreme Court and en banc Federal Circuit decisions in Akamai Technologies, Inc. v. Limelight Networks, Inc. The co-authors explain that not only should litigants consider Akamai’s ruling when forming their infringement strategy, but the courts’ decisions and future decisions interpreting its contours will likely have important implications for developing and managing patent portfolios across a range of industries and technologies.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.